Research Trial for Plaque Psoriasis (98 Days)

Plaque Psoriasis patients (aged 18 to 65) may qualify for this research trial testing an investigational treatment. Eligible participants must have been diagnosed with plaque psoriasis for at least 6 months prior to screening, and have moderate to severe disease involving 10% or more body surface area. Failing to fully respond to or are intolerant to at least one topical therapy for psoriasis, is also required.

Participants will receive investigational oral medication (active study drug) or placebo. Investigational medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 98 days and involve about 7 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more